Lexicon Pharmaceuticals Inc (LXRX) Volatility Spurs A Quest For Clarity

Currently, there are 361.49M common shares owned by the public and among those 168.72M shares have been available to trade. The company’s stock has a 5-day price change of -10.50% and -56.70% over the past three months. LXRX shares are trading -4.43% year to date (YTD), with the 12-month market performance down to -52.31% lower. […]

Investors Should Take Note Of Lexicon Pharmaceuticals Inc (LXRX)

Lexicon Pharmaceuticals Inc (LXRX) concluded trading on Wednesday at a closing price of $0.86, with 3.82 million shares of worth about $3.28 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -46.28% during that period and on January 08, 2025 the price saw a […]

Lexicon Pharmaceuticals Inc (NASDAQ: LXRX): Stock That Needs Special Handling

Currently, there are 361.49M common shares owned by the public and among those 168.63M shares have been available to trade. The company’s stock has a 5-day price change of 0.31% and -54.68% over the past three months. LXRX shares are trading -52.01% year to date (YTD), with the 12-month market performance down to -43.52% lower. […]

Look For Institutional Buying In Lexicon Pharmaceuticals Inc (NASDAQ: LXRX)

Lexicon Pharmaceuticals Inc (LXRX) concluded trading on Wednesday at a closing price of $0.89, with 15.67 million shares of worth about $13.94 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -53.89% during that period and on December 11, 2024 the price saw a […]

Analysts Update Their Price Forecasts For Lexicon Pharmaceuticals Inc (LXRX)

Lexicon Pharmaceuticals Inc (LXRX) concluded trading on Wednesday at a closing price of $0.69, with 4.04 million shares of worth about $2.79 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -61.07% during that period and on December 04, 2024 the price saw a […]

Growing Through Challenges? – Lexicon Pharmaceuticals Inc (LXRX)

Currently, there are 244.93M common shares owned by the public and among those 238.68M shares have been available to trade. Insiders at the company have transacted a total of 56 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 47 of these insider trades were purchases, […]

Lexicon Pharmaceuticals Inc (NASDAQ: LXRX): The Best-Of-Breed For Investing?

Currently, there are 244.93M common shares owned by the public and among those 238.79M shares have been available to trade. Insiders at the company have transacted a total of 56 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 47 of these insider trades were purchases, […]

Lexicon Pharmaceuticals Inc (NASDAQ: LXRX): Analyst View Points To Future Growth

Lexicon Pharmaceuticals Inc (LXRX) concluded trading on Wednesday at a closing price of $2.15, with 4.03 million shares of worth about $8.66 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 18.13% during that period and on Wednesday February 7 the price saw a […]

Are Analysts Expecting A Better 2020 For Lexicon Pharmaceuticals Inc (LXRX)?

Lexicon Pharmaceuticals Inc (LXRX) concluded trading on Wednesday at a closing price of $1.87, with 4.94 million shares of worth about $9.23 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -3.61% during that period and on Wednesday, January 31 the price saw a […]